Journal Home
Search for

Volume 20, Issue 6, Pages 521-528 (November 2009)


View previous. 12 of 12

Drug testing in Australian schools: Policy implications and considerations of punitive, deterrence and/or prevention measures

Ann M. RocheCorresponding Author Informationemail address, Petra Bywood1email address, Ken Pidd1email address, Toby Freeman1email address, Tania Steenson1email address

Received 1 July 2008; received in revised form 25 March 2009; accepted 2 April 2009. published online 18 May 2009.

Abstract 

Background

There have been increasing national and international calls for the introduction of drug testing as a policy measure to address harmful drug use. Such strategies have been applied in workplaces, sporting arenas, prisons and more latterly school settings. They are predicated on a belief in their efficacy in reducing drug-related harm, a need to ‘send the right’ message to potential users and to reassure the community at large that ‘something is being done.’ Rigorous examination is required of purported benefits of drug testing in schools.

Methods

A comprehensive examination was made of testing efficacy and accuracy. Australian legal and ethical issues, encompassing duty of care, rights of the child and privacy determinations, were juxtaposed with that of the United States of America.

Results

Evidence examined indicates no compelling case for the application of drug testing and that caution should be applied when considering drug testing as a drug detection and prevention strategy in the school setting.

Conclusion

While this review did not support school drug testing, there are alternative evidence-based strategies that schools can implement to prevent drug-related problems among student populations.

National Centre for Education and Training on Addiction Flinders University2, Adelaide, Australia

Corresponding Author InformationCorresponding author at: Flinders University, National Centre for Education and Training, Bedford Park, SA5042, Australia. Fax: +61 08 8201 7550.

1 Fax: +61 08 8201 7550.

PII: S0955-3959(09)00061-9

doi:10.1016/j.drugpo.2009.04.002


View previous. 12 of 12